Stødkilde, L., Nørregaard, R., Fenton, R. A., Wang, G., Knepper, M. A.
& Frøkiær, J. (2011).
Bilateral ureteral obstruction induces early downregulation and redistribution of AQP2 and phosphorylated AQP2.
American Journal of Physiology: Renal Physiology,
301(1), F226-35.
https://doi.org/10.1152/ajprenal.00664.2010
Stødkilde, K., Nielsen, J. T., Petersen, S. V., Paetzold, B.
, Brüggemann, H., Mulder, F. A. A. & Andersen, C. B. F. (2022).
Solution Structure of the Cutibacterium acnes-Specific Protein RoxP and Insights Into Its Antioxidant Activity.
Frontiers in cellular and infection microbiology,
12, Artikel 803004.
https://doi.org/10.3389/fcimb.2022.803004
Stock, S. J., Zoega, H., Brockway, M., Mulholland, R. H., Miller, J. E., Been, J. V., Wood, R., Abok, I. I., Alshaikh, B., Ayede, A. I., Bacchini, F., Bhutta, Z. A., Brew, B. K., Brook, J., Calvert, C., Campbell-Yeo, M., Chan, D., Chirombo, J., Connor, K. L. ... iPOP Study Team (2021).
The international Perinatal Outcomes in the Pandemic (iPOP) study: Protocol.
Wellcome Open Research,
6, Artikel 21.
https://doi.org/10.12688/wellcomeopenres.16507.1Stochholm, K., Gravholt, C. H., Laursen, T., Jørgensen, J. O. L., Laurberg, P., Andersen, M., Kristensen, L. Ø., Feldt-Rasmussen, U.
, Christiansen, J. S., Frydenberg, M. & Green, A. (2006).
Incidence of GH deficiency: a nationwide study. European Journal of Endocrinology,
155(1), 61-71.
Stochholm, K., Laursen, T., Green, A.
, Laurberg, P., Andersen, M., Kristensen, L. Ø., Feldt-Rasmussen, U.
, Christiansen, J. S., Frydenberg, M. & Gravholt, C. H. (2008).
Morbidity and GH deficiency: a nationwide study.
European Journal of Endocrinology,
158(4), 447-57.
https://doi.org/10.1530/EJE-07-0523
Stjernholm, T.
, Andersen, P. O., Nielsen, A. L.-L., Johansen, C., Iversen, L., Kjeldsen, C. R. & Stenderup, K. (2017).
Leptin-deficiency in ob/ob mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin induces a psoriatic phenotype in human keratinocytes.
Experimental Dermatology, 338-345. Artikel 26(4).
Stilund, M. L., Møller, H. J., Reuschlein, A.
, Petersen, T., Rasmussen, P. V. & Christensen, T. (2011).
Soluble CD163 as a diagnostic marker in multiple sclerosis.
Multiple Sclerosis,
17(S10), 499.
Stilund, M. L., Møller, H. J., Reuschlein, AK.
, Christensen, T., Rasmussen, P. V. & Petersen, T. (2012).
Soluble CD163 as a diagnostic marker in multiple sclerosis. Poster-session præsenteret på PhD Day 2012, Aarhus, Danmark.
Stilund, M. L., Møller, H. J., Reuschlein, AK.
, Christensen, T., Rasmussen, P. V. & Petersen, T. (2013).
Soluble CD163 as a diagnostic marker in multiple sclerosis. Poster-session præsenteret på Aarhus University Graduate School of Health, PhD Day 2013, Aarhus, Danmark.
Stilund, M. L., Møller, H. J., Christensen, T., Reuschlein, A.-K.
, Rasmussen, P. V. & Petersen, T. (2013).
Soluble CD163 in cerebrospinal fluid of patients with multiple sclerosis. Poster-session præsenteret på 29th ECTRIMS Congress, Copenhagen, Danmark.
Stilund, M. L., Møller, H. J., Christensen, T., Reuschlein, A.-K.
, Rasmussen, P. V. & Petersen, T. (2013).
Soluble CD163 in cerebrospinal fluid of patients with multiple sclerosis.
Multiple Sclerosis,
19 (SI), 298.
Stilund, M. L., Reuschlein, A.-K., Christensen, T., Møller, H. J., Rasmussen, P. V. & Petersen, T. (2014).
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis.
PLoS One,
9(6), e98588.
Stilund, M. L., Gjelstrup, M. C., Petersen, T., Møller, H. J., Rasmussen, P. V. & Christensen, T. (2014).
Diagnostic contribution of soluble CD163 to a panel of biomarkers in newly diagnosed patients with multiple sclerosis. Multiple Sclerosis,
20 SI, 179.
Stilund, M. L., Gjelstrup, M. C., Petersen, T., Møller, H. J., Rasmussen, P. V. & Christensen, T. (2015).
Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
PLoS One,
10(4), Artikel e0119681.
https://doi.org/10.1371/journal.pone.0119681
Stilund, M. L., Gjelstrup, M. C., Christensen, T., Møller, H. J. & Petersen, T. (2016).
A multi-biomarker follow-up study of patients with multiple sclerosis.
Brain and Behavior,
6(9), Artikel e00509.
https://doi.org/10.1002/brb3.509
Stilund, M. L. M., Carstensen, M., Petersen, T.
, Møller, H. J. & Christensen, T. (2021).
Monocyte and Macrophage Markers in Multiple Sclerosis. Poster-session præsenteret på The 34th virtual conference of the European Macrophage and Dendritic cell Society (EMDS), Aarhus, Danmark.
Stidsen, J. V., Henriksen, J. E., Olsen, M. H.
, Thomsen, R. W., Nielsen, J. S., Rungby, J., Ulrichsen, S. P., Berencsi, K., Kahlert, J. A., Friborg, S. G., Brandslund, I., Nielsen, A. A.
, Christiansen, J. S., Sørensen, H. T., Olesen, T. B. & Beck-Nielsen, H. (2018).
Pathophysiology-based phenotyping in type 2 diabetes: A clinical classification tool.
Diabetes/Metabolism Research and Reviews,
34(5), 1-11. Artikel e3005.
https://doi.org/10.1002/dmrr.3005Stewart, T., Sossi, V., Aasly, J. O., Wszolek, Z. K., Uitti, R. J., Hasegawa, K., Yokoyama, T., Zabetian, C. P., Leverenz, J. B., Stoessl, A. J., Wang, Y., Ginghina, C., Liu, C., Cain, K. C., Auinger, P., Kang, U. J.
, Jensen, P. H., Shi, M. & Zhang, J. (2015).
Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity.
Acta Neuropathologica Communications,
3(7).
https://doi.org/10.1186/s40478-015-0185-3Stewart, L. M., Gerner, L., Rettel, M., Stein, F., Burrows, J. F.
, Mills, I. G. & Evergren, E. (2021).
CaMKK2 facilitates Golgi-associated vesicle trafficking to sustain cancer cell proliferation.
Cell Death and Disease,
12(11), Artikel 1040.
https://doi.org/10.1038/s41419-021-04335-xStern, N., Korotkova, M., Strandvik, B.
, Oxlund, H., Öberg, M., Håkansson, H. & Lind, P. M. (2005).
Subchronic toxicity of baltic herring oil and its fractions in the rat (III). Bone tissue composition and dimension, and ratio of n-6/n-3 fatty acids in serum phospholipids.
Basic Clin. Pharmacol. Toxicol.,
96(6), 453-464.
Stern, M. A.
, Dahl, R., Nielsen, L. P., Pedersen, B. & Schrewelius, C. (1997).
A comparison of aqueous suspensions of budesonide nasal spray (128 micrograms and 256 micrograms once daily) and fluticasone propionate nasal spray (200 micrograms once daily) in the treatment of adult patients with seasonal allergic rhinitis.
American Journal of Rhinology & Allergy,
11(4), 323-30.
http://dx.doi.org/10.2500/105065897781446658Stephens, R. W., Nielsen, H. J., Christensen, I. J.
, Thorlacius-Ussing, O., Sørensen, S., Danø, K. & Brünner, N. (1999).
Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis.
Journal of the National Cancer Institute,
91(10), 869-74.
Stenvang, M., Dueholm, M. S.
, Vad, B. S., Seviour, T. W., Zeng, G., Geifman-Shochat, S., Søndergaard, M. T.
, Christiansen, G., Meyer, R. L., Kjelleberg, S.
, Otzen, D. E. & Nielsen, P. H. (2016).
Epigallocatechin Gallate Remodels overexpressed Functional Amyloids in Pseudomonas aeruginosa and Increases Biofilm Susceptibility to Antibiotic Treatment.
Journal of Biological Chemistry,
291(51), 26540-26553.
https://doi.org/10.1074/jbc.M116.739953
Stenvang, M., Schafer, N. P., Malmos, K. G., Pérez, A.-M. W., Niembro, O., Sormanni, P.
, Basaiawmoit, R. V., Christiansen, G., Andreasen, M. & Otzen, D. E. (2018).
Corneal dystrophy mutations drive pathogenesis by targeting TGFBIp stability and solubility in a latent amyloid-forming domain.
Journal of Molecular Biology,
430(8), 1116-1140.
https://doi.org/10.1016/j.jmb.2018.03.001
Stentebjerg-Olesen, B., Pallesen, L., Jensen, LB.
, Christiansen, G. & Klemm, P. (1997).
Authentic display of a cholera toxin epitope by chimeric type 1 fimbriae: effects of insert position and host background. Microbiol.,
143, 2027-2038.
Stengaard-Pedersen, K., Thiel, S., Gadjeva, M., Møller-Kristensen, M.
, Sørensen, R., Jensen, L. T., Sjøholm, A. G.
, Fugger, L. & Jensenius, J. C. (2003).
Inherited deficiency of mannan-binding lectin-associated serine protease 2.
The New England Journal of Medicine,
349(6), 554-60.
https://doi.org/10.1056/NEJMoa022836
Stenderup, K., Rosada, C., Worsaae, A.
, Dagnaes-Hansen, F., Steiniche, T., Hasselager, E.
, Iversen, L., Zahn, S., Wöldike, H., Holmberg, H. L.
, Rømer, J., Kragballe, K., Clausen, J. T. & Dam, T. N. (2008).
Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model.
British Journal of Dermatology,
160(2), 284-96.
https://doi.org/10.1111/j.1365-2133.2008.08890.x
Stenderup, K., Rosada, C., Justesen, J., Al-Soubky, T.
, Dagnaes-Hansen, F. & Kassem, M. (2004).
Aged human bone marrow stromal cells maintaining bone forming capacity in vivo evaluated using an improved method of visualization.
Biogerontology,
5(2), 107-18.
https://doi.org/10.1023/B:BGEN.0000025074.88476.e2
Stender, J., Kupers, R.
, Rodell, A., Thibaut, A., Chatelle, C., Bruno, M.-A.
, Gejl, M., Bernard, C., Hustinx, R., Laureys, S.
& Gjedde, A. (2015).
Quantitative rates of brain glucose metabolism distinguish minimally conscious from vegetative state patients.
Journal of Cerebral Blood Flow and Metabolism,
35(1), 58-65.
https://doi.org/10.1038/jcbfm.2014.169Stempel, M., Chan, B., Juranić Lisnić, V., Krmpotić, A., Hartung, J.
, Paludan, S. R., Füllbrunn, N., Lemmermann, N. A. W. & Brinkmann, M. M. (2019).
The herpesviral antagonist m152 reveals differential activation of STING-dependent IRF and NF-κB signaling and STING's dual role during MCMV infection.
EMBO Journal,
38(5), Artikel e100983.
https://doi.org/10.15252/embj.2018100983Stelzer, I., Fuchs, R., Schraml, E., Quan, P., Hansalik, M., Pietschmann, P., Quehenberger, F., Skalicky, M.
, Viidik, A. & Schauenstein, K. (2010).
Decline of bone marrow-derived hematopoietic progenitor cell quality during aging in the rat.
Experimental Aging Research,
36(3), 359-70.
https://doi.org/10.1080/0361073X.2010.484785Steinwerth, P., Bertrand, J., Sandt, V., Marchal, S.
, Sahana, J., Bollmann, M., Schulz, H., Kopp, S.
, Grimm, D. & Wehland, M. (2024).
Structural and Molecular Changes of Human Chondrocytes Exposed to the Rotating Wall Vessel Bioreactor.
Biomolecules,
14(1), Artikel 25.
https://doi.org/10.3390/biom14010025Steinkamp, A.-D., Seling, N.
, Lee, S., Boedtkjer, E. & Bolm, C. (2015).
Synthesis of N-cyano-substituted sulfilimine and sulfoximine derivatives of S0859 and their biological evaluation as sodium bicarbonate co-transport inhibitors.
MedChemComm,
6, 2163-2169.
Steiniche, T., Christiansen, P. M., Vesterby, A., Ullerup, R., Hessov, I.
, Mosekilde, L. & Melsen, F. (2000).
Primary hyperparathyroidism: Bone structure, balance, and remodeling before and 3 years after surgical treatment.
Bone,
26, 535-543.
Steinert, G., Oancea, C., Roos, J., Hagemeyer, H.
, Maier, T., Ruthardt, M. & Puccetti, E. (2011).
Sulindac sulfide reverses aberrant self-renewal of progenitor cells induced by the AML-associated fusion proteins PML/RARα and PLZF/RARα.
PLoS One,
6(7), e22540.
https://doi.org/10.1371/journal.pone.0022540Steiner, P. D., Forrer, R., Kneissel, M., Gasser, J. A.
, Thomsen, J. S., Mosekilde, L. & Riond, J. L. (2001).
Influence of a low calcium and phosphorus diet on the anabolic effect of human parathyroid hormone (1-38) in female rats.
Bone,
29(4), 344-351.
https://doi.org/10.1016/S8756-3282(01)00506-3Steinbrüchel, D. A.
, Madsen, H. H., Nielsen, B., Larsen, S., Koch, C., Jensenius, J. C., Hougesen, C. & Kemp, E. (1990).
Treatment with total lymphoid irradiation, cyclosporin A and a monoclonal anti-T-cell antibody in a hamster-to-rat heart transplantation model: graft survival and morphological analysis.
Transplant International,
3(1), 36-40.
Steinbrink, S. D., Pergola, C., Bühring, U., George, S., Metzner, J., Fischer, A. S., Häfner, A.-K., Wisniewska, J. M., Geisslinger, G., Werz, O., Steinhilber, D.
& Maier, T. (2010).
Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations.
Cellular and molecular life sciences : CMLS,
67(5), 797-806.
https://doi.org/10.1007/s00018-009-0206-0Steinberg, S.
, Mors, O., Børglum, A. D., Gustafsson, O., Werge, T.
, Mortensen, P. B., Andreassen, O. A., Sigurdsson, E.
, Thorgeirsson, T. E., Böttcher, Y., Olason, P., Ophoff, R. A., Cichon, S., Gudjonsdottir, I. H., Pietiläinen, O. P. H.
, Nyegaard, M., Tuulio-Henriksson, A., Ingason, A.
, Hansen, T. ... Genetic Risk and Outcome in Psychosis (2011).
Expanding the range of ZNF804A variants conferring risk of psychosis.
Molecular Psychiatry,
16(1), 59-66.
https://doi.org/10.1038/mp.2009.149Steinberg, S., de Jong, S., Andreassen, O. A., Werge, T.
, Børglum, A. D., Mors, O., Mortensen, P. B., Gustafsson, O., Costas, J., Pietiläinen, O. P. H.
, Demontis, D., Papiol, S., Huttenlocher, J., Mattheisen, M., Breuer, R., Vassos, E., Giegling, I., Fraser, G., Walker, N. ... Irish Schizophrenia Genomics Consortium (2011).
Common Variants at VRK2 and TCF4 Conferring Risk of Schizophrenia.
Human Molecular Genetics,
20(20), 4076-81.
https://doi.org/10.1093/hmg/ddr325Steinberg, S., de Jong, S., Mattheisen, M., Costas, J.
, Demontis, D., Jamain, S., Pietiläinen, O. P. H., Lin, K., Papiol, S., Huttenlocher, J., Sigurdsson, E., Vassos, E., Giegling, I., Breuer, R., Fraser, G., Walker, N., Melle, I., Djurovic, S., Agartz, I. ... GROUP (2014).
Common variant at 16p11.2 conferring risk of psychosis.
Molecular Psychiatry,
19(1), 108-114.
https://doi.org/10.1038/mp.2012.157Steffensen, K. D., Waldstrøm, M., Olsen, D. A.
, Corydon, T., Lorentzen, K. A., Knudsen, H. J., Jeppesen, U., Brandslund, I.
& Jakobsen, A. (2008).
Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors.
Clinical Cancer Research,
14(11), 3278-82.
https://doi.org/10.1158/1078-0432.CCR-07-4171Steffensen, R., Thiel, S., Varming, K., Jersild, C.
& Jensenius, J. C. (2000).
Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers.
Journal of Immunological Methods,
241(1-2), 33-42.
Steffensen, L. B., Mortensen, M. B., Kjolby, M., Hagensen, M. K., Oxvig, C. & Bentzon, J. F. (2015).
Disturbed Laminar Blood Flow Vastly Augments Lipoprotein Retention in the Artery Wall: A Key Mechanism Distinguishing Susceptible From Resistant Sites.
Arteriosclerosis, Thrombosis, and Vascular Biology,
35, 1928-1935.
https://doi.org/10.1161/ATVBAHA.115.305874